This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Oura Health Oy. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Henri Huttunen: Innovator in Neurotrophic Factors
Introduction: Henri Huttunen is an inventor based in Helsinki, Finland. He is currently associated with Herantis Pharma Plc., where he focuses on the development of innovative treatments for various diseases. Although he has not yet been granted any patents, his work in the field of unconventional neurotrophic factors is noteworthy.
Latest Patent Applications: Henri Huttunen has been involved in several significant patent applications. One of his latest applications is titled "MACROCYCLIC PEPTIDES." This disclosure relates to the field of unconventional neurotrophic factors and aims to treat degenerative, chronic, or progressive diseases and disorders, as well as monogenic hereditary diseases associated with ER stress. The application discusses modified peptides, particularly macrocyclic peptides, and their pharmaceutical compositions for use as medicaments.
Another important application is "RETRO-INVERSO PEPTIDES." Similar to the previous application, this disclosure also pertains to unconventional neurotrophic factors and addresses the treatment of degenerative diseases and disorders. It focuses on modified peptides, specifically retro-inverso peptides, and their potential pharmaceutical applications.
Conclusion: Henri Huttunen is making strides in the field of neurotrophic factors through his innovative research and patent applications. His contributions may lead to significant advancements in the treatment of various diseases and disorders.